CTRI/2019/11/022147招募中未知
A randomized,double-blind, placebo controlled study to evaluate the efficacy and safety of Garcinol 20% with Curcumin 250mg in patients with Non-Alcoholic Steatohepatitis without liver cirrhosis.
Sami Labs Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient has given informed consent for participation in this study.
- •2.BMI between 25 to 35 kg/m2.
- •3.Patient with presence of mild to moderate steatosis NASH (<= stage 2) without or with fibrosis(<= grade 2) by: Diagnosis of NASH based on elevated ALT and Ultrasonography.
- •4.Patient with controlled Diabetes, Hyper- lipidemia & Hypertension by stable dose for at least 3 months prior to screening.
排除标准
- •1.Patients having age below 30 and above 65
- •2.Pregnant and lactating females not included in this study.
- •3.HbA1c more than 7.2.
- •4.Patients having other systemic complications like hepatic, renal and cardiac problems
- •5.Patient with history of alcoholism
- •6.Those are not willing to participate in trial and not ready to give written consent.
- •7.History of renal, pulmonary, epileptic, hematologic, cardio -vascular, neurological or psychiatric illness and immuno -eficiency diseases
- •8.Patients who are currently participating in any other clinical trials (since last 3 months).
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the effect of choline-stabilized orthosilicic acid (ch-OSA®) in patients with tennis elbowateral epicondylitisMusculoskeletal DiseasesLateral epicondylitisISRCTN12631735Bio Minerals NV148
进行中（未招募）
Unknown
Efficacy of herbal supplements (CL22209 and CL22205) on polycystic ovary syndrome (PCOS)CTRI/2023/11/059457CLS Pvt Ltd
已完成
3 期
A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer who received no prior therapy for advanced disease (CLEE011A2301)advanced breast cancerNL-OMON55670ovartis24
进行中（未招募）
1 期
Study of efficacy and safety of LEE011 in postmenopausal women with advanced breast cancer.EUCTR2013-003084-61-BEovartis Pharma Services AG650
进行中（未招募）
1 期
Efficacy and Safety of RAD001 in patients aged 18 and over with Angiomyolipoma associated with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)EUCTR2008-002113-48-GBovartis Pharma Services AG118